Founded in 2001 in Malvern, Pennsylvania, Reaction Biology was created to provide outstanding kinase-based drug discovery to labs worldwide.
They have quickly become the go-to CRO for kinase screening and holding true to their promise for high-quality data and support they have continuously developed assays for new target classes. 20 years later, they offer thousands of assays and a platform for integrated drug discovery.
With a second research location in Germany (former ProQinase GmbH), a global business development team and collaborators they have truly become a leading CRO for drug discovery in the world.
To find out more about Reaction Biology contact Alessandro Mantell, CEO, on +44 (0)20 3778 0990 or alessandro@mantellassociates.com.